Abacus Life Offers $25M Notes, Secure Top Market Spotby Mark Eisenberg 12.02.2024Abacus Life has announced the pricing of a $25 million public offering to refinance debt. With strong financial growth, the ...
W.P. Carey Stock: Buy or Sell After Dip?by Mark Eisenberg 12.02.2024W. P. Carey & Co. faces downgrade and concerns after stock decline due to credit issues and non-renewal, but oversold ...
Invizyne Technologies: Nasdaq Debut with $17.2M Offeringby Mark Eisenberg 12.02.2024Invizyne Technologies files registration statement with SEC for public offering. Offering consists of 4.3 million shares priced at $4.00 per ...
Cidara Therapeutics: $11.1M European Approval Milestoneby Mark Eisenberg 12.02.2024Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
AGF Management Expands Alternatives Business with New Holland Stakeby Mark Eisenberg 12.02.2024Canadian asset management firm AGF Management has made a strategic investment in New York-based investment manager New Holland Capital as ...
Wish Sells to Qoo10 for $173M: Aiming for Revivalby Mark Eisenberg 12.02.2024ContextLogic, the company behind Wish, will sell most of its assets to Qoo10 for $173M in cash. This move aims ...
CNX’s $400M Move: Strategic Shift or Risky?by Mark Eisenberg 12.02.2024CNX Resources raises $400 million in senior notes offering and launches tender offer, positioning the company for future growth in ...
Saudi Market Hits Record High: Pharma Leads, Oil Slipsby Terry Bingman 12.02.2024The Saudi Arabia stock market hits a new 52-week high as pharmaceutical and telecom stocks surge, attracting investor attention.
Tod’s Stock Surges 17% Amid Delisting and Takeover Rumorsby Terry Bingman 12.02.2024Shares of Tod's SpA surged 17% after a delisting plan and takeover bid by L Catterton, valuing the luxury goods ...
Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investmentby Mark Eisenberg 12.02.2024Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...